SONO TEK CORP Q2 FY2027 earnings call

• Strong First Half Performance: Delivered solid progress with revenue growth, meaningful gross margin expansion (from 51% to 55%), and improved operating profitability.
• Strategic Shift to Production: Customers are transitioning from process development/qualification to commercial manufacturing, driving demand for higher-value, larger production systems.
• Record Order Activity: Announced three orders totaling ~$7.2 million from an existing alternative energy customer for 10 production-scale systems, the largest aggregate order in company history.
• Backlog Visibility: Backlog as of August 31 was ~$9.5 million; subsequent orders (including a >$3.6M medical diagnostic line) bring total backlog to over $10.79 million, with majority expected in FY2028.
• Forward Deployed Engineering (FDE): Expanded FDE team to four personnel to support systems integration capabilities, accelerating the transition from R&D to high-volume production solutions.
• Balance Sheet Strength: Maintained a pristine balance sheet with no debt and cash/marketable securities of ~$17.7 million, providing flexibility for investment and working capital needs.

Revenue increased 6% to approximately $10.9 million for the first half of fiscal 2027, with gross margin expanding to 55%. The Medical market was the primary growth driver, contributing approximately $7.1 million in sales (up 289%), representing roughly 65% of total revenue. Industrial business grew significantly by approximately 156%, driven by defense-related optics shipments. Alternative Energy saw reduced demand due to policy changes but secured a major new order. Multi-access coating systems increased ~50%, OEM systems increased ~67%, while Inline coding systems declined 14% due to unfavorable prior-year comparisons.

• Reiterated expectation for flat to modest revenue growth for the remainder of fiscal 2027.
• Noted that timing of large production system orders may cause quarter-to-quarter variability.
• Expressed increased visibility into fiscal 2028 due to recent record order activity and strong backlog.
• Anticipated continued encouraging demand, particularly in medical devices and high-value production platforms.

• Revenue Variability: Large, high-ASP system orders can create significant quarter-to-quarter revenue volatility based on shipment timing.
• Market Policy Dependence: Alternative energy demand is sensitive to government policy and spending changes, which recently impacted green hydrogen and fuel cell applications.
• Margin Fluctuation: Gross margins vary based on product mix, geographic distribution, and specific system shifts; current elevated margins may not be indicative of future periods.
• Capacity Constraints: Rapid growth in large orders requires immediate capacity expansion; failure to scale manufacturing infrastructure could hinder fulfillment.
• Customer Concentration: Significant reliance on key accounts in medical and alternative energy sectors for high-value orders.

Q: Analyst asked about the 'flywheel effect' of integrated orders where customers expand production lines, requiring follow-on equipment without acquiring new customers.

A: Management confirmed this model drives higher ASPs and repeat business. They highlighted investments in the Forward Deployed Engineering (FDE) team to integrate ultrasonic tech into larger production platforms. This approach yields faster ROI than core R&D, leveraging decades of technology to capture high-volume manufacturing opportunities as customers scale.

Q: Analyst questioned the sustainability of elevated gross margins and the impact of shifting from R&D to production machines.

A: Management explained that margins improve significantly on repeat orders (machines 2-15) due to cost optimization. High-ASP systems shipping to US customers avoid distributor discounts, further boosting margins. They anticipate these favorable conditions becoming the norm rather than the exception as more high-volume production orders enter the backlog.

Q: Analyst inquired about the strategic focus on the Defense sector following a recent optics-related shipment.

A: Management expressed bullishness on Defense, citing growing demand for optics in flying objects/sensors. While not yet heavily marketed there, they see strong fit with high-tech, less price-sensitive applications. They plan to address compliance requirements and potentially add a dedicated Defense tab to their website, viewing it as a lucrative new vertical.

Q: Analyst asked about capacity constraints given the surge in large orders and the timeline for facility expansion.

A: Management outlined a phased expansion: Phase 1 (mezzanine/building optimization) starting late calendar year to increase capacity to $33-36M; Phase 2 (retrofitting unused building) to reach $44-45M. They noted that only 2-4 significant multi-million dollar orders could necessitate a structural move beyond current footprint, prompting early planning for a potential jump to $80M+ capacity.

Q: Analyst sought clarity on the reporting structure and role of the Forward Deployed Engineering team versus Sales/Application Engineering.

A: Management clarified that FDE engineers report to the Application Engineering Manager, who bridges R&D lab proofs and production scaling. FDEs handle 2-3 major accounts while generating proposals for new ones. The Project Manager supports coordination, ensuring technical expertise flows directly to sales for accurate forecasting and seamless transition from R&D to production orders.